GIP and type 2 diabetes mellitus: However, Stensen et al. (21) recently showed that treatment of diabetic individuals with a selective GIP receptor antagonist lowered plasma insulin levels after a mixed meal, indicating that endogenous GIP retains considerable insulinotropic activity in T2D.